Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival.

被引：0
|
作者：
Cen, Putao
Chan, Kok Hoe
Canfield, Steven
Shu, Tung
Maithel, Neha
Tammisetti, Varaha
机构：
[1] Univ Texas Hlth Sci Ctr Houston UTHealth Houston, McGovern Med Sch, Houston, TX USA
[2] Univ Texas Med Sch Houston, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer
    Muto, Satoru
    Abe, Hideyuki
    Noguchi, Takahiro
    Sugiura, Sho-ichiro
    Kitamura, Kousuke
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Kamai, Takao
    Horie, Shigeo
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (05) : 490 - 494
  • [22] Real-world survival and treatment patterns of patients with locally advanced or metastatic urothelial carcinoma treated with second-line therapy after platinum-based chemotherapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Grande, Enrique
    Bamias, Aristotelis
    Galsky, Matthew D.
    Kikuchi, Eiji
    Davis, Ian D.
    Arranz, Jose Angel
    Kalebasty, Arash Rezazadeh
    del Muro, Xavier Garcia
    Park, Se Hoon
    De Giorgi, Ugo
    Alekseev, Boris
    Mencinger, Marina
    Izumi, Kouji
    Puente, Javier
    Li, Jian-Ri
    Bernhard, Sandrine
    Nicholas, Alan
    Telliez, Julie
    De Santis, Maria
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 58 : 28 - 36
  • [24] Utility of ATP7B in Prediction of Response to Platinum-based Chemotherapy in Urothelial Bladder Cancer
    Schmid, Sebastian Christoph
    Schuster, Tibor
    Horn, Thomas
    Gschwend, Juergen
    Treiber, Uwe
    Weirich, Gregor
    ANTICANCER RESEARCH, 2013, 33 (09) : 3731 - 3737
  • [25] EV-301: An open-label, randomized phase III study to evaluate enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC)
    Petrylak, D. P.
    Rosenberg, J.
    Duran, I.
    Loriot, Y.
    Sonpavde, G.
    Wu, C.
    Gartner, E.
    Melhem-Bertrandt, A.
    Powles, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Early response to platinum-based chemotherapy in non small cell lung cancer (NSCLC) predicts survival.
    Sirohi, B
    Matakidou, A
    Ashley, S
    Popat, S
    Saka, W
    Priest, K
    Norton, A
    James, M
    Benepal, T
    Eisen, T
    O'Brien, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 672S - 672S
  • [27] Clinical outcomes with platinum-based chemotherapy after progression on frontline immunotherapy in metastatic urothelial cancer (mUC)
    Szabados, B. E.
    Stockem, C. F.
    Gauna, D. E. Castellano
    Lista, A. Gomez De Liano
    Cardenas, M. Rey
    Valderrama, B. Perez
    Powles, T. B.
    van der Heijden, M. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1346 - S1346
  • [28] Complete response after neoadjuvant chemotherapy for locally advanced bladder urothelial carcinoma-2 case reports
    Pai, I-Wei
    Hsu, Jong-Ming
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A262 - A263
  • [29] Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy
    Furubayashi, Nobuki
    Negishi, Takahito
    Sakamoto, Naotaka
    Shimokawa, Hozumi
    Morokuma, Futoshi
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Tokuda, Noriaki
    Seki, Narihito
    Kuroiwa, Kentaro
    Nakamura, Motonobu
    ONCOTARGETS AND THERAPY, 2021, 14 : 1981 - 1988
  • [30] EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors
    O'Donnell, P.
    Galsky, M. D.
    Rosenberg, J. E.
    Petrylak, D. P.
    Balar, A. V.
    McGregor, B. A.
    Heath, E.
    Yu, E. Y.
    Quinn, D. I.
    Hahn, N. M.
    Campbell, M.
    Liang, S-Y.
    Steinberg, J.
    Loriot, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S579 - S580
12345